International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.09 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 22,500 shares.
International Stem Cell Price Performance
The firm’s 50 day moving average is $0.10 and its 200 day moving average is $0.09. The firm has a market cap of $920,460.00, a P/E ratio of -1.44 and a beta of 0.05.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Articles
- Five stocks we like better than International Stem Cell
- Using the MarketBeat Dividend Tax Calculator
- Is Myers Industries Poised for a Breakout?
- Market Cap Calculator: How to Calculate Market Cap
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
